Literature DB >> 25082578

Modeling CVD in human pluripotent cells by genome editing.

Roger J Hajjar1, Jean-Sebastien Hulot2.   

Abstract

Entities:  

Keywords:  cardiomyopathies; disease modeling; genetics; genome editing; stem cells

Mesh：

Substances：

Year:  2014        PMID： 25082578      PMCID： PMC4724803          DOI： 10.1016/j.jacc.2014.06.005

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  15 in total

Review 1.  Genome editing with engineered zinc finger nucleases.

Authors:  Fyodor D Urnov; Edward J Rebar; Michael C Holmes; H Steve Zhang; Philip D Gregory
Journal:  Nat Rev Genet       Date:  2010-09       Impact factor: 53.242

2.  Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.

Authors:  Irene C Turnbull; Ioannis Karakikes; Gregory W Serrao; Peter Backeris; Jia-Jye Lee; Chaoqin Xie; Grant Senyei; Ronald E Gordon; Ronald A Li; Fadi G Akar; Roger J Hajjar; Jean-Sébastien Hulot; Kevin D Costa
Journal:  FASEB J       Date:  2013-10-30       Impact factor: 5.191

3.  Utilization of the AAVS1 safe harbor locus for hematopoietic specific transgene expression and gene knockdown in human ES cells.

Authors:  Amita Tiyaboonchai; Helen Mac; Razveen Shamsedeen; Jason A Mills; Siddarth Kishore; Deborah L French; Paul Gadue
Journal:  Stem Cell Res       Date:  2014-02-21       Impact factor: 2.020

Review 4.  Cas9 as a versatile tool for engineering biology.

Authors:  Prashant Mali; Kevin M Esvelt; George M Church
Journal:  Nat Methods       Date:  2013-10       Impact factor: 28.547

5.  Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome.

Authors:  Xonia Carvajal-Vergara; Ana Sevilla; Sunita L D'Souza; Yen-Sin Ang; Christoph Schaniel; Dung-Fang Lee; Lei Yang; Aaron D Kaplan; Eric D Adler; Roye Rozov; Yongchao Ge; Ninette Cohen; Lisa J Edelmann; Betty Chang; Avinash Waghray; Jie Su; Sherly Pardo; Klaske D Lichtenbelt; Marco Tartaglia; Bruce D Gelb; Ihor R Lemischka
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 6.  Impact of genetics on the clinical management of channelopathies.

Authors:  Peter J Schwartz; Michael J Ackerman; Alfred L George; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2013-05-15       Impact factor: 24.094

7.  Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing.

Authors:  Yongming Wang; Ping Liang; Feng Lan; Haodi Wu; Leszek Lisowski; Mingxia Gu; Shijun Hu; Mark A Kay; Fyodor D Urnov; Rami Shinnawi; Joseph D Gold; Lior Gepstein; Joseph C Wu
Journal:  J Am Coll Cardiol       Date:  2014-08-05       Impact factor: 24.094

8.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

9.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

10.  Comprehensive analysis of the specificity of transcription activator-like effector nucleases.

Authors:  Alexandre Juillerat; Gwendoline Dubois; Julien Valton; Séverine Thomas; Stefano Stella; Alan Maréchal; Stéphanie Langevin; Nassima Benomari; Claudia Bertonati; George H Silva; Fayza Daboussi; Jean-Charles Epinat; Guillermo Montoya; Aymeric Duclert; Philippe Duchateau
Journal:  Nucleic Acids Res       Date:  2014-02-24       Impact factor: 16.971
View more
  2 in total

1.  Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.

Authors:  Ioannis Karakikes; Francesca Stillitano; Mathieu Nonnenmacher; Christos Tzimas; Despina Sanoudou; Vittavat Termglinchan; Chi-Wing Kong; Stephanie Rushing; Jens Hansen; Delaine Ceholski; Fotis Kolokathis; Dimitrios Kremastinos; Alexandros Katoulis; Lihuan Ren; Ninette Cohen; Johannes M I H Gho; Dimitrios Tsiapras; Aryan Vink; Joseph C Wu; Folkert W Asselbergs; Ronald A Li; Jean-Sebastien Hulot; Evangelia G Kranias; Roger J Hajjar
Journal:  Nat Commun       Date:  2015-04-29       Impact factor: 14.919

2.  Type 2 diabetes associated variants of KCNQ1 strongly confer the risk of cardiovascular disease among the Saudi Arabian population.

Authors:  Maha S Al-Shammari; Rhaya Al-Ali; Nader Al-Balawi; Mansour S Al-Enazi; Ali A Al-Muraikhi; Fadi N Busaleh; Ali S Al-Sahwan; Abdulmohsen Al-Elq; Awatif N Al-Nafaie; Jesu Francis Borgio; Sayed AbdulAzeez; Amein Al-Ali; Sadananda Acharya
Journal:  Genet Mol Biol       Date:  2017-08-31       Impact factor: 1.771
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.